Trial Identifier: | D7551C00003 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel
|
Start Date: | February 2021 |
Primary Completion Date: | March 2021 |
Study Completion Date: | March 2021 |
Condition: | Chronic Kidney Diseases |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version |
Country | Location |
---|---|
United Kingdom | London, United Kingdom, HA1 3UJ |